Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
The Schmooze

Pill Makes Fasting Easier

Israeli Arabs may soon make your Yom Kippur fast easier.

It’s often said that Jews and Muslims have a lot in common when it comes to religious observance, and that’s rarely highlighted better than when it comes to fasting. Both religions require full-on fasting several times a year.

Now there’s a theory that a drug called etoricoxib (commercial name Arcoxia), if taken before a fast day, reduces the occurrence of migraines and headaches. Before Yom Kippur, doctors at Jerusalem’s Shaare Zedek Medical Center gave 211 patients pills to take — some were placebos, others were etoricoxib. Those who took the real thing — which conveniently remains active in the body for 22 hours — reported an easier fast.

The same researchers are working with Muslims who are fasting through Ramadan to continue their research, and if all goes well, they may just find a cure to fast-related migraines. On their recruitment website, they present the participation in the research as a religious virtue, as it will test whether the drug will “decrease the incidence of people breaking their fast.” You can see more on the experiment in this piece in the Jerusalem Post.

A message from our CEO & publisher Rachel Fishman Feddersen

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

At a time when other newsrooms are closing or cutting back, the Forward has removed its paywall and invested additional resources to report on the ground from Israel and around the U.S. on the impact of the war, rising antisemitism and polarized discourse.

Readers like you make it all possible. Support our work by becoming a Forward Member and connect with our journalism and your community.

—  Rachel Fishman Feddersen, Publisher and CEO

Join our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.